Yuhan Corporation (KRX:000100)

South Korea · Delayed Price · Currency is KRW

83,100

+1,100 (1.34%)

Aug 11, 2026, 9:25 AM KST

-27.42% (1Y)

Market Cap	6.11T -28.6%
Revenue (ttm)	2.22T +5.1%
Net Income	209.30B +217.8%
EPS	2,804.37 +214.3%
Shares Out	74.76M
PE Ratio	29.24
Forward PE	51.87
Dividend	500.00 (0.62%)
Ex-Dividend Date	Feb 26, 2026

Volume	28,426
Open	82,400
Previous Close	82,000
Day's Range	81,600 - 83,600
52-Week Range	65,000 - 129,200
Beta	0.40
Analysts	Buy
Price Target	121,777.78 (+46.54%)
Earnings Date	Aug 14, 2026

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1926

Employees 2,087

Stock Exchange Korea Stock Exchange

Ticker Symbol 000100

Full Company Profile

Financial Performance

In 2025, Yuhan's revenue was 2.19 trillion, an increase of 5.75% compared to the previous year's 2.07 trillion. Earnings were 191.09 billion, an increase of 170.33%.

Financial Statements

Analyst Summary

According to 18 analysts, the average rating for 000100 stock is "Buy." The 12-month stock price target is ₩121,778, which is an increase of 46.54% from the latest price.

Price Target

₩121,778

(46.54% upside)

Analyst Consensus: Buy

Stock Forecasts